Skip to content

Current Debt at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$11.69B+1.4%
CONMED logo
CONMEDCNMD
$177.2M+24,718%
Vericel logo
VericelVCEL
$116K-1.7%
Enovis logo
EnovisENOV
$35M+74.8%
OrthoPediatrics logo
OrthoPediatricsKIDS
$2.22M+148%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$18.52B-1.4%
Enterprise value$25.57B-0.9%
P/E24.3×+1.5×
P/S2.2×-0.2×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's current debt?
Zimmer Biomet Holdings (ZBH) reported current debt of $1.18B in Q1 2026.
How has Zimmer Biomet Holdings's current debt changed year-over-year?
Zimmer Biomet Holdings's current debt increased by 96.0% year-over-year, from $600M to $1.18B.
What is the long-term trend for Zimmer Biomet Holdings's current debt?
Over 5 years (2020 to 2025), Zimmer Biomet Holdings's current debt has grown at a 3.3% compound annual growth rate (CAGR), from $500M to $587.1M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.